APOE 4 and hip fracture risk in a community-based study of older adults

Journal of the American Geriatrics Society

Volumn 47, Issue 11, 1999, Pages 1342-1345

  Johnston, Janet M ^a,b   Cauley, Jane A ^b   Ganguli, Mary ^b,c  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

APOE; Apolipoprotein E; Community study; Hip fracture

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; VITAMIN K GROUP;

AGED; AGING; ALLELE; ARTICLE; DEMENTIA; FALLING; FEMALE; GENOTYPE; HIP FRACTURE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PSYCHIATRIC DIAGNOSIS; RISK ASSESSMENT; RISK FACTOR; VITAMIN METABOLISM;

EID: 0032692787     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1999.tb07436.x     Document Type: Article

References (26)

1. Mahley RW. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.
2. Poirier J. Apolipoprotein E in the brain and its role in Alzheimer's disease. J Psychiatry Neurosci 1996;21:128-134.
3. Wang XL, McCredie RM, Wilcken DEL. Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Arterioscler Thromb Vasc Biol 1995;15:1030-1034.
4. Wilson P, Schaefer E, Larson M, Ordovas J. Apolipoprotein E alleles and risk of coronary disease: A meta-analysis. Arterioscler Thromb Vasc Biol 1996;16:1250-1255.
5. Evans DA, Beckett LA, Field TS et al. Apolipoprotein E ∈4 and incidence of Alzheimer disease in a community population of older persons. JAMA 1997; 277:822-824.
6. Myers RH, Schaefer EJ, Wilson PWF et al. Apolipoprotein E ∈4 association with dementia in a population-based study: The Framingham study. Neurology 1996;46:673-677.
7. Saunders AM, Strittmatter WJ, Schmechel D et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
8. Strittmatter WJ, Saunders AM, Schmechel D et al. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 1993;90: 1977-1981.
9. Kohlmeier M, Saupe J, Schaefer K, Asmus G. Bone fracture history and prospective bone fracture risk of hemodialysis patients are related to apolipoprotein E genotype. Calcif Tissue Int 1998;62:278-281.
10. Cauley JA, Zmuda JM, Yaffe K et al. Apolipoprotein E polymorphism: A new genetic marker of hip fracture risk - the Study of Osteoporotic Fractures. J Bone Miner Res 1999;14:1175-1181.
11. Shiraki M, Shiraki W, Aoki C et al. Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 1997;12;1438-1445.
12. Ganguli M, Belle S, Ratcliff G et al. Sensitivity and specificity for dementia of population-based criteria for cognitive impairment: The MoVIES project. J Gerontol 1993;48:M152-161.
13. Ganguli M, Lytle ME, Reynolds MD, Dodge HH. Random versus volunteer selection for a community-based study. J Gerontol 1998;53:M39-46.
14. Kamboh MI, Aston CE, Hamman RF. The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a bi-ethnic population from the San Luis Valley, Colorado. Atherosclerosis 1995; 112:145-159.
15. Ganguli M, Ratcliff G, DeKosky ST. Cognitive test scores in community-based older adults with and without dementia. Aging Mental Health 1997;1: 176-180.
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association, 1987.
17. Morris JC. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 1993;43:2412-2414.
18. Fillenbaum GG, Heyman A, Huber MS et al. The prevalence and 3-year incidence of dementia in older black and white community residents. J Clin Epidemiol 1998;51:587-595.
19. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-130.
20. Liang KY, Zeger SL. Longitudinal data analysis using general linear models. Biometrika 1986;73:13-22.
21. Kamboh MI, Sepehrnia B, Ferrell RE. Genetic studies of human apolipoproteins: VI. Common polymorphism of apolipoprotein E in blacks. Dis Markers 1989;7:49-55.
22. Kannus P, Parkkari J, Sievanen H et al. Epidemiology of hip fracture. Bone 1996;18(suppl):S57-63.
23. Melton LJ, Beard CM, Atkinson EJ, O'Fallon WM. Fracture risk in patients with Alzheimer's disease. J Am Geriatr Soc 1994;42:614-619.
24. Kohlmeier M, Salomon A, Saupe J, Shearer J. Transport of vitamin K to bone in humans. J Nutr 1996;126(suppl): S1192-1196.
25. Vermeer C, Gijsbers MG, Craciun M et al. Effects of vitamin K on bone mass and bone metabolism. J Nutr 1996;126(suppl): S1187-1191.
26. Nevitt MC, Cummings SR, Browner WS et al. The accuracy of self-report of fractures in elderly women: Evidence from a prospective study. Am J Epidemiol 1992;135:490-499.